New cancer target for non-Hodgkin’s lymphoma

(New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin’s lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.

source : www.eurekalert.org

Related News:

• Accelerating The Pace Of Discovery In Cancer Research
• SGO: New Option for Recurrent Ovarian Cancer? (CME/CE)
• Impact Of Ethnicity On Primary Treatment Choice And Mortality In Men With Prostate Cancer: Data From CaPSURE
• Gaps Remain in Cancer Palliative Care (CME/CE)
• Cordyceps mushroom is an effective cancer treatment, states new research
• Insufficiency Fractures After Pelvic Radiotherapy In Patients With Prostate Cancer
• Genetic variations influence statin efficacy for lowering colon cancer risk
• Heart transplant patients face greater risk of skin cancer
• How Cells Protect Themselves From Cancer
• The optimal Rx for pancreatic cancer: Stop it before it starts